Advisornet Financial’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-58
| Closed | -$335 | – | 2086 |
|
|
2024
Q3 | $335 | Hold |
58
| – | – | ﹤0.01% | 2050 |
|
|
2024
Q2 | $469 | Hold |
58
| – | – | ﹤0.01% | 1934 |
|
|
2024
Q1 | $805 | Hold |
58
| – | – | ﹤0.01% | 1815 |
|
|
2023
Q4 | $357 | Hold |
58
| – | – | ﹤0.01% | 2190 |
|
|
2023
Q3 | $272 | Hold |
58
| – | – | ﹤0.01% | 2095 |
|
|
2023
Q2 | $313 | Hold |
58
| – | – | ﹤0.01% | 2141 |
|
|
2023
Q1 | $574 | Hold |
58
| – | – | ﹤0.01% | 2037 |
|
|
2022
Q4 | $1.09K | Hold |
58
| – | – | ﹤0.01% | 1808 |
|
|
2022
Q3 | $1K | Hold |
58
| – | – | ﹤0.01% | 1754 |
|
|
2022
Q2 | $1K | Hold |
58
| – | – | ﹤0.01% | 1792 |
|
|
2022
Q1 | $3K | Hold |
58
| – | – | ﹤0.01% | 1710 |
|
|
2021
Q4 | $3K | Buy |
58
+37
| +176% | +$1.91K | ﹤0.01% | 1737 |
|
|
2021
Q3 | $2K | Hold |
21
| – | – | ﹤0.01% | 1744 |
|
|
2021
Q2 | $2K | Hold |
21
| – | – | ﹤0.01% | 1670 |
|
|
2021
Q1 | $2K | Hold |
21
| – | – | ﹤0.01% | 1615 |
|
|
2020
Q4 | $2K | Buy |
+21
| New | +$2K | ﹤0.01% | 1526 |
|
|
2020
Q3 | – | Sell |
-40
| Closed | -$13K | – | 1782 |
|
|
2020
Q2 | $13K | Buy |
+40
| New | +$13K | ﹤0.01% | 1210 |
|
|
2019
Q4 | – | Sell |
-246
| Closed | -$6K | – | 1914 |
|
|
2019
Q3 | $6K | Sell |
246
-3
| -1% | -$73 | ﹤0.01% | 1489 |
|
|
2019
Q2 | $9K | Hold |
249
| – | – | ﹤0.01% | 1253 |
|
|
2019
Q1 | $11K | Hold |
249
| – | – | ﹤0.01% | 1150 |
|
|
2018
Q4 | $12K | Hold |
249
| – | – | ﹤0.01% | 1040 |
|
|
2018
Q3 | $17K | Buy |
249
+146
| +142% | +$9.97K | ﹤0.01% | 994 |
|
|
2018
Q2 | $5K | Hold |
103
| – | – | ﹤0.01% | 1281 |
|
|
2018
Q1 | $6K | Buy |
103
+102
| +10,200% | +$5.94K | ﹤0.01% | 1191 |
|
|
2017
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1266 |
|